PROS1 and major depressive disorder: The present report provides morphometric and western blot-based evidence that the in situ immunoreactivity and the estimated levels of some ECM proteoglycans and axonal protein NF186 are significantly altered in CUS and MDD either as a consequence of stress or due to pathological processes underlying MDD.